IL87755A - Solubility modulated drug delivery device - Google Patents

Solubility modulated drug delivery device

Info

Publication number
IL87755A
IL87755A IL87755A IL8775588A IL87755A IL 87755 A IL87755 A IL 87755A IL 87755 A IL87755 A IL 87755A IL 8775588 A IL8775588 A IL 8775588A IL 87755 A IL87755 A IL 87755A
Authority
IL
Israel
Prior art keywords
solubility
delivery device
drug delivery
modulated drug
modulated
Prior art date
Application number
IL87755A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL87755A publication Critical patent/IL87755A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL87755A 1987-09-24 1988-09-15 Solubility modulated drug delivery device IL87755A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10066487A 1987-09-24 1987-09-24
US11548787A 1987-11-02 1987-11-02

Publications (1)

Publication Number Publication Date
IL87755A true IL87755A (en) 1992-03-29

Family

ID=26797415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87755A IL87755A (en) 1987-09-24 1988-09-15 Solubility modulated drug delivery device

Country Status (11)

Country Link
EP (1) EP0314206B1 (pt)
JP (1) JP2915416B2 (pt)
KR (1) KR960009409B1 (pt)
AU (1) AU608891B2 (pt)
CA (1) CA1320886C (pt)
DE (1) DE3885232T2 (pt)
DK (1) DK528988A (pt)
ES (1) ES2059495T3 (pt)
IE (1) IE61620B1 (pt)
IL (1) IL87755A (pt)
PT (1) PT88565B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
FR2698560B1 (fr) * 1992-11-30 1995-02-03 Virbac Laboratoires Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications.
GB9609094D0 (en) * 1996-05-01 1996-07-03 Univ Strathclyde Delivery device
IL118932A0 (en) * 1996-07-24 1996-10-31 Dexcel Ltd Controlled release tablets
JP4863534B2 (ja) * 1996-10-25 2012-01-25 スパーナス ファーマシューティカルズ インコーポレイテッド 可溶形態浸透用量送達システム
US6074669A (en) * 1997-01-20 2000-06-13 Ranbaxy Laboratories Limited Controlled drug delivery system for diltiazem
DE19941769A1 (de) 1999-09-02 2001-03-08 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
JP2003521506A (ja) * 2000-02-04 2003-07-15 アルザ・コーポレーション 浸透圧で駆動される液体ディスペンサーとコーティング組成物
US6824763B2 (en) 2002-05-30 2004-11-30 Kimberly-Clark Worldwide, Inc. Anti-fungal powder having enhanced excipient properties
CN100522960C (zh) 2004-04-08 2009-08-05 惠氏公司 作为黄体酮受体调节剂的硫代酰胺衍生物
MXPA06012403A (es) 2004-04-27 2007-01-17 Wyeth Corp Purificacion de moduladores de receptor progesterona.
WO2006009801A2 (en) 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
US7759312B2 (en) 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
EP1888043A4 (en) 2005-03-11 2010-07-28 Endo Pharmaceuticals Solutions OCTREOTIDE FORMULATIONS WITH CONTROLLED RELEASE
WO2007037158A1 (ja) * 2005-09-28 2007-04-05 Tti Ellebeau, Inc. カプセル型薬物放出装置及びカプセル型薬物放出装置システム
US9173773B2 (en) * 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
KR101574354B1 (ko) 2007-04-27 2015-12-04 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 이식 장치 이형제 및 이의 사용 방법
UA104866C2 (uk) 2008-06-25 2014-03-25 Ендо Фармас'Ютікалз Солюшнз Інк. Імплантат октреотиду, який містить вивільняючу речовину
JP5622725B2 (ja) 2008-06-25 2014-11-12 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓｉｎｃ． エキセナチド及び他のポリペプチド類の持続的送達
WO2010015840A1 (en) * 2008-08-08 2010-02-11 Cipla Limited Osmotic delivery device with modified release
WO2012172449A1 (en) 2011-06-13 2012-12-20 Pfizer Inc. Lactams as beta secretase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump
CA1331563C (en) * 1987-08-03 1994-08-23 Gaylen M. Zentner Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents

Also Published As

Publication number Publication date
JPH0291017A (ja) 1990-03-30
KR960009409B1 (ko) 1996-07-19
DE3885232D1 (de) 1993-12-02
DE3885232T2 (de) 1994-04-07
AU2212988A (en) 1989-04-06
JP2915416B2 (ja) 1999-07-05
IE882898L (en) 1989-03-24
ES2059495T3 (es) 1994-11-16
EP0314206A1 (en) 1989-05-03
PT88565A (pt) 1988-10-01
CA1320886C (en) 1993-08-03
PT88565B (pt) 1993-03-31
IE61620B1 (en) 1994-11-16
KR890004679A (ko) 1989-05-09
EP0314206B1 (en) 1993-10-27
DK528988D0 (da) 1988-09-23
DK528988A (da) 1989-05-18
AU608891B2 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
IL87755A (en) Solubility modulated drug delivery device
GB8712975D0 (en) Drug delivery device
GB8712176D0 (en) Drug delivery system
GB8609218D0 (en) Drug delivery device
GB2185397B (en) Drug delivery system
GB2185187B (en) Transdermal drug delivery device
EP0232155A3 (en) Drug delivery system
ZA873091B (en) Pulsed drug delivery
AU7717287A (en) Drug infusion device
GB8710094D0 (en) Pulsed drug delivery
IL86076A (en) Transdermal drug delivery device
IL86802A0 (en) Drug delivery devices
PT80525B (en) Sustained release drug delivery device
GB9016056D0 (en) Transdermal medicine delivery devices
ZA887009B (en) A solubility modulated drug delivery device
IL82675A (en) Drug delivery apparatus
GB8715911D0 (en) Drug delivery device
GB8706780D0 (en) Drug delivery device
GB8622697D0 (en) Drug delivery device
GB8613382D0 (en) Drug delivery device
GB8620226D0 (en) Drug delivery device
EP0412158A4 (en) Oncostatic drug
AU3034589A (en) Intraruminal drug delivery device
IL82753A0 (en) Transdermal drug delivery device
IL83469A0 (en) Transdermal drug delivery device

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees